Follow us on Twitter
for the latest Class Action Settlement News!
Lipozene and MetaboUp False Advertising Class Action Lawsuit
By Matt O’Donnell
Obesity Research Institute has been hit with a false advertising class action lawsuit for making claims “too good to be true” about its diet drugs/supplements, Lipozene and MataboUp.
According to the class action lawsuit, Obesity Research Institute uses bold fonts and “official looking seals” on its product packaging that lead consumers to believe that Lipozene and MataboUp diet pills are clinically proven to “reduce pounds of body fat and weight without a change in lifestyle.” The products also misleadingly state that not only users will lose weight merely by taking the product, but that 78% of each pound lost will be pure body fat.
“In reality, the too good to be true claims made by Obesity Research Institute are just that and the Defendant is and has been misrepresenting the effectiveness of its weight loss products to the general public in order to reap windfall profits,” the Lipozene and MataboUp class action lawsuit states.
As a result, consumers have been unfairly duped into paying $29.95 a bottle for diet pills that do not provide the advertising benefits “whatsoever.”
The MataboUp and Lipozene class action lawsuit is brought on behalf of all persons, nationwide, who purchased Obesity Research Institute’s diet products, including a sub-class of California residents who purchased the products. It is seeking class certification, damages and restitution for alleged violations of the Consumers Legal Remedies Act, false advertising, unfair competition, breach of express warranty, and breach of implied warranty.
Updated January 6th, 2012
Originally Published November 1st, 2011
All class action and lawsuit news updates are listed in the Lawsuit News section of Top Class Actions
LEGAL INFORMATION IS NOT LEGAL ADVICE
©2008 – 2012 Top Class Actions® LLC
Various Trademarks held by their respective owners.
View all: Class Action Lawsuit and Settlement News